ArticleFrontiers in bioinformatics2025
Comprehensive analysis of multi-omics vaccine response data using MOFA and Stabl algorithms.
Article in Frontiers in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biomarker discovery and patient stratification in pancreatic cancer using incomplete multi-omics data.PLoS computational biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: FluPRINT is a multi-omics dataset that measures donors' protein expression and cell counts across various assays. Donors were also assigned a binary value (0 or 1), being labeled as high responders if they had a fold change ≥4 of the antibody titer for hemagglutination inhibition (HAI) from day 0 to day 28, and low responders otherwise (0). In this project, we used the MOFA and Stabl algorithms to analyze FluPRINT, estimate the population structure from the data, and identify the most important features for predicting response to the vaccine. Methods: The preprocessing of the dataset included removing repeat features, scaling by assay, and removing outliers. Since Stabl does not directly address missing values, features with high amounts of missing values were removed and the remaining were ignored. Results: MOFA identified the top feature in structure extraction as IL neg 2 CD4 pos CD45Ra neg pSTAT5. MOFA explains well the variance of the data while also choosing features that have good significance, as illustrated by their significant p-values (p < 0.05). Stabl found the top feature for explaining the outcome to be CD33 Discussion: Our research addresses a key knowledge gap: understanding how these fundamentally different analytical approaches perform when analyzing the same complex dataset. Our exploration evaluates their respective strengths, limitations, and biological insights and provides guidance on using MOFA and Stabl to find the best predictive cell subsets and features for understanding large immunological multi-omics data. The code for this project can be found at https://github.com/aanya21gupta/fluprint.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.